Netherlands· NL-751b87e00a7a

Ancotil, oplossing voor infusie 10 mg/ml

A flucytosine product containing flucytosine, registered in Netherlands by Viatris Healthcare B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC J02AX01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about flucytosineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Flucytosine is registered in 8 of 19 countries.

Countries holding a registration under ATC J02AX01 (flucytosine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search flucytosine products by name

Flucytosine · ATC J02AX01

8 / 19 countries

Czechiaprice
Finlandprice
Germany
Netherlands
Norwayprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flucytosine costs, country by country.

Normalised to the WHO defined daily dose (10 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Flucytosine · price per daily dose (10 g)

USD · FX 28 Sept 2026

FR France$11.41

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FLUCYTOSINE
Manufacturer: Viatris Healthcare B.V.
Country: Netherlands (NL)
ATC code: J02AX01
ATC class: Flucytosine
Defined daily dose: 10 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
08533

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

99 interactions on record for flucytosine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check flucytosine against other medicines How interaction checks work

Flucytosine · interactions on record

99 records

4 severe
93 moderate
1 minor

Most severe, free to view

CladribineL01BB04severe
CladribineL04AA40severe
ClozapineN05AH02severe
DeferiproneV03AC02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flucytosine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flucytosine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

Austria · Ancotil
Germany · Ancotil
France · Ancotil
United Kingdom (Northern Ireland) · Ancotil
Italy · Ancotil
Sweden · Ancotil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/8ed8ba2c-14d5-4263-8883-c2fbf75e7f0e
GET /v1/drugs/8ed8ba2c-14d5-4263-8883-c2fbf75e7f0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08533_smpc.pdf",
  "strength": null,
  "atc_label": "Flucytosine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg08533",
  "excipients": [
    "NATRIUMCHLORIDE",
    "TROMETAMOL",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FLUCYTOSINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h08533.pdf",
  "authorised_at": "1981/02/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "08533",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about flucytosine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console